Endometrial carcinoma may favor partial, but not complete, loss of the TGF-β signaling pathway

Proc Natl Acad Sci U S A. 2019 May 7;116(19):9164-9165. doi: 10.1073/pnas.1903646116.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Endometrial Neoplasms*
  • Female
  • Humans
  • Infertility*
  • Mice
  • Signal Transduction
  • Smad2 Protein
  • Smad3 Protein
  • Transforming Growth Factor beta

Substances

  • SMAD2 protein, human
  • SMAD3 protein, human
  • Smad2 Protein
  • Smad3 Protein
  • Transforming Growth Factor beta